All In Biotech

Drug Trial Radar · NCT05704738

A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study With Re-randomization to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO)

Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 532 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

532

Actual

Start

Apr 20, 2023

Primary completion

Feb 27, 2025

Study completion Nov 25, 2025

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jan 30, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent participants.

Conditions

  • Atopic Dermatitis

Interventions

  • RocatinlimabDrug

    Subcutaneous (SC) injection

  • PlaceboDrug

    SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Who Achieved vIGA-AD 1 Response With Presence of Only Barely Perceptible Erythema or vIGA-AD 0 Response (Revised Investigator's Global Assessment [rIGA] 0/1) at Week 24Time frame: Baseline and Week 24
  2. Number of Participants Who Achieved EASI 75 at Week 24Time frame: Baseline and Week 24

Locations

246 sites in 22 countries. Site status is shown where the registry gives one.

  • Cahaba Dermatology and Skin Health Center

    Birmingham, Alabama

  • AllerVie Clinical Research- Cullman

    Cullman, Alabama

  • Eclipse Clinical Research

    Tucson, Arizona

  • Arkansas Research Trials, LLC

    North Little Rock, Arkansas

  • Center for Dermatology Clinical Research Inc

    Fremont, California

  • Doc1 Healthcare Systems Incorporated

    Fullerton, California

  • Axon Clinical Research

    Inglewood, California

  • Avance Clinical Trials

    Laguna Niguel, California

  • Cura Clinical Research

    Palmdale, California

  • Integrative Skin Science and Research

    Sacramento, California

  • University of California at Davis Medical Center

    Sacramento, California

  • Allergy and Asthma Medical Group and Research Center

    San Diego, California

  • University of California at San Diego Rady Childrens Hospital San Diego

    San Diego, California

  • Clinical Science Institute

    Santa Monica, California

  • Cura Clinical Research Sherman Oaks

    Sherman Oaks, California

  • Velocity Clinical Research - Denver

    Denver, Colorado

  • Childrens National Medical Center

    Washington D.C., District of Columbia

  • Clinical Research of Brandon

    Brandon, Florida

  • Academic Alliance in Dermatology - Saint Petersburg Office

    Clearwater, Florida

  • Corazon United States of America, LLC doing business as Life Clinical Trials

    Coral Springs, Florida

  • Palm Beach Dermatology Group

    Delray Beach, Florida

  • Direct Helpers Research Center

    Hialeah, Florida

  • Glick Skin Institute

    Margate, Florida

  • Miami Clinical Research

    Miami, Florida

  • ara Professionals Limited Liability Corporation

    Miami, Florida

  • Deluxe Health Care LLC

    Miami Lakes, Florida

  • Savin Medical Group LLC

    Miami Lakes, Florida

  • Angels Clinical Research Institute

    Miami Lakes, Florida

  • Optimal Research Sites, LLC

    Orange City, Florida

  • Clinical Associates of Orlando Limited Liability Company

    Orlando, Florida

  • Clinical Research Investments

    Orlando, Florida

  • University of South Florida

    Tampa, Florida

  • Centricity Research Columbus

    Columbus, Georgia

  • Advanced Medical Research PC

    Sandy Springs, Georgia

  • Divine Dermatology and Aesthetics

    Savannah, Georgia

  • McIntosh Clinic PC

    Thomasville, Georgia

  • Treasure Valley Medical Research

    Boise, Idaho

  • Velocity Clinical Research - Boise

    Meridian, Idaho

  • NorthShore University HealthSystem Clinical Trials Center

    Skokie, Illinois

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

Showing 40 of 246 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.